|
US2016015318A1
|
|
Physiological monitor system for determining medication delivery and outcome
|
|
AU2012203630A1
|
|
Gateway platform for biological monitoring and delivery of therapeutic compounds
|
|
AU2011202767A1
|
|
Hydration monitoring
|
|
US2011208067A1
|
|
Vascular patency management using electric fields
|
|
US2011224578A1
|
|
Use of electric fields to minimize rejection of implanted devices and materials
|
|
US2011230732A1
|
|
System utilizing physiological monitoring and electronic media for health improvement
|
|
AU2007329219A1
|
|
Platform for detection of tissue content and/or structural changes with closed-loop control in mammalian organisms
|
|
AU2007304956A1
|
|
Foreign body response detection in an implanted device
|
|
WO2008021226A1
|
|
Platform for detection of tissue structure change
|
|
WO2006029034A2
|
|
Monitoring platform for detection of hypovolemia, hemorrhage and blood loss
|
|
CA2552976A1
|
|
Multiple section parenteral drug delivery apparatus
|
|
CA2548307A1
|
|
Structures and devices for parenteral drug delivery and diagnostic sampling
|
|
US7783344B2
|
|
Hydration monitoring
|
|
US7044911B2
|
|
Gateway platform for biological monitoring and delivery of therapeutic compounds
|
